You can see a global supply chain under the guise of a lunch special when you walk into practically any sushi counter in America. The Pacific or Indian Ocean is most likely where the tuna originated. The shrimp were probably raised in Indonesia, India, or Ecuador. Approximately 94% of the seafood consumed by Americans originates from overseas, and this fact will become much more significant than most diners are aware.
The FDA’s strategy for handling imported seafood has been akin to a slow-moving filter for many years: it inspects a sample here, flags a shipment there, and issues an import alert when trends become severe enough. It hasn’t been combative. For years, the Southern Shrimp Alliance and other critics have claimed that it has hardly been operational. However, that is changing. Increased fraud detection, more stringent genetic tracing, and—most importantly—a request to Congress for the authority to physically destroy contaminated shipments rather than simply reject them at the dock are all included in the agency’s 2026 priority list.
Before you realize what it’s replacing, that final piece seems bureaucratic. The current regulations allow an importer to try another port if their shrimp or eel is rejected at one. The FDA cited a specific case from 2023 in which a wholesaler was found smuggling in more than 2,100 cartons of frozen eel that had previously been rejected due to carcinogenic fungicide residue. This practice is known as port shopping, and it appears to be widespread enough. He was given 15 months. According to the agency itself, such cases are uncommon and simple to replicate.
The math for importers quickly changes when the option to simply reroute a rejected shipment is eliminated. A flagged container is now a write-off rather than a delay. Long before the product ever makes it to a Brooklyn izakaya or an Ohio strip mall sushi restaurant, this alters behavior upstream in processing facilities in Vietnam or shrimp ponds in Indonesia.
It’s important to state clearly that no one is advocating for a sushi ban. However, the seafood industry operates on thin margins and thinner timing, so any new friction at the border usually manifests as price increases, menu substitutions, and, if conditions tighten sufficiently, outright shortages of particular species. Contamination-related supply scares have already occurred at Eel. The most popular seafood in the nation, shrimp, has seen an increase in rejections due to radioactive contamination concerns from Indonesia and prohibited antibiotics from India. A system with less leeway than it has had in decades would result from the addition of destruction authority and more stringent screening.
There is a plausible argument that this is past due. Customers may have a right to know that their nigiri isn’t made with prohibited veterinary medications. However, there is also a more subtle risk that no one in Washington seems to be discussing much: family-run small sushi restaurants lack the purchasing power to adjust to abrupt price fluctuations or switch to alternative sourcing the way a national chain can.
How quickly any of this moves is still unknown. The Destruction of Hazardous Imports Act passed committee with a vote of 43–0, indicating that there isn’t much political disagreement. Louisiana shrimpers and proponents of seafood safety seldom agree on anything, and this is no exception. The speed of implementation, consistency of enforcement, and the ability of the FDA’s historically underfunded inspection division to truly carry out a stricter mandate without additional resources are less certain.
The politics don’t stand out when you watch this play out. It’s the difference between how imperceptible seafood sourcing is to the typical diner and how vulnerable it actually becomes when regulators start tugging on a few threads.
